Home
Atara Bio

Atara Bio Market Share Analysis for March 2026

Find more than a career, Help find solutions. Fill out general application, and we will find a right position for you, or notify you when a right one becomes available.

Health > Biotechnology and Pharmaceuticals

Domainatarabio.com

Year Founded2012

Employees201 - 500

Annual Revenue$100M - $200M

Atara Bio

Atara Bio (including company regionals)

atarabio.com

See more website traffic and engagement information

Atara Bio Revenue up to March 2026 is 100M - 200M

revenue generated by Atara Bio top domains

Atara Bio top domains revenue over 3 years

Revenue for Atara Bio top domains

atarabio.com100M - 200M

See more with Sales Intelligence

Total visits to Atara Bio's top domains

Understand Atara Bio market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

atarabio.com12.8K

See more with Sales Intelligence

Avg. visit duration in Atara Bio's top domains

Analyze Atara Bio engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

atarabio.com00:00:13

See more with Sales Intelligence

Avg. pageviews on Atara Bio's top domains

See how Atara Bio keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

atarabio.com1.67

See more with Sales Intelligence

Atara Bio top competitors by domain

Top similar sites in March 2026, ranked by their affinity

zymeworks.comCompany NameZymeworksEmployees201 - 500HQCanada, VancouverAnnual revenue$25M - $50MTotal visits23KHealth > Biotechnology and Pharmaceuticals

Top technologies used by Atara Bio

These are the website technologies, by industry, used by Atara Bio top domains

Payment & Currencies (7)

Cart Functionality

Advertising (5)

DoubleClick

Widget (5)

Twemoji

Conversion & Analytics (4)

Google Analytics

More Technologies

13

See all

News & Signals from Atara Bio

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsAtara Biotherapeutics, Inc. has issues with manufacturing problems and deficiencies in its ALLELE study.Atara suffered from manufacturing problems and deficiencies in its ALLELE study which made it unlikely that the FDA would approve its BLA for tabelecleucel.

NewsGlancy Prongay & Murray LLP filed suit against Atara Biotherapeutics, Inc. on Apr 10th '26.LOS ANGELES, April 10, 2026 /PRNewswire/ - Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ: ATRA).

NewsBragar Eagel & Squire PC files suit against Atara Biotherapeutics, Inc..* Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Atara Biotherapeutics, Inc. ("Atara" or the "Company") (NASDAQ:ATRA) in the United States District Court for the Central District of California on behalf of all persons and entities who purchased or otherwise acquired Atara securities between May 20, 2024 and January 9, 2026, both dates inclusive (the "Class Period").